Wosulin-30/70 100IU/mL
Pajjiż: Filippini
Lingwa: Ingliż
Sors: FDA (Food And Drug Administration)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Biphasic Isophane Insulin Human (Recombinant DNA Origin)
Disponibbli minn:
Ambica International Corp.; Distributor: GX Laboratories, Inc.
INN (Isem Internazzjonali):
Biphasic Isophane Insulin Human (Recombinant DNA Origin)
Dożaġġ:
100IU/mL
Għamla farmaċewtika:
Suspension for Injection (SC) (30% Regular Insulin Human/70% Isophane Insulin Human)
Unitajiet fil-pakkett:
USP Type I clear and Colourless glass cartridge x 3mL (Box of 1's), USP Type I clear and colorless glass cartridge x 3mL (box of
Manifatturat minn:
Wockhardt Ltd., India
Sommarju tal-prodott:
Suspension for Injection (SC) (30% Regular Insulin Human/70% Isophane Insulin Human)
Data ta 'l-awtorizzazzjoni:
2019-01-28
